NASDAQ : AKBA

Akebia Therapeutics, Inc.

$1.4 USD

$0.02 (1.45%)

Volume
3.06M
Average Volume
5.12M
Market Capitalization
$375.56M
P/E Ratio
-18.16
Dividend Yield
0.00%
Price Target
$4.00
Year High
$4.04
Year Low
$0.82
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.40

AKBA Estimated and Actual Revenue by Quarter

AKBA Estimated and Actual EPS by Quarter

AKBA Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 -8.32M -7.01M -7.87M -14.31M -12.06M -13.54M
2027-09-30 2 -7.81M -6.58M -7.39M -13.43M -11.32M -12.71M
2027-06-30 2 -7.42M -6.25M -7.02M -12.75M -10.75M -12.07M
2027-03-31 1 -7.13M -6.01M -6.75M -12.27M -10.34M -11.61M
2026-12-31 2 -10.63M -8.96M -10.06M -18.28M -15.41M -17.3M
2026-09-30 3 -9.36M -9.01M -9.18M -16.1M -15.49M -15.8M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 -24.37M -19.48M -22.7M 22.28M 26.42M 25M
2027-09-30 2 -24.37M -19.48M -22.7M 20.91M 24.81M 23.47M
2027-06-30 2 -24.37M -19.48M -22.7M 19.86M 23.56M 22.29M
2027-03-31 1 -24.37M -19.48M -22.7M 19.1M 22.66M 21.44M
2026-12-31 2 -6.88M -5.5M -6.41M 28.47M 33.77M 31.96M
2026-09-30 3 -16.38M -8.19M -12.28M 28.62M 29.73M 29.17M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 37.99M 45.06M 42.64M 1 -0.09127343 -0.07294741 -0.085
2027-09-30 2 35.66M 42.3M 40.03M 1 -0.09127343 -0.07294741 -0.085
2027-06-30 2 33.87M 40.17M 38.02M 1 -0.09127343 -0.07294741 -0.085
2027-03-31 1 32.58M 38.64M 36.57M 1 -0.09127343 -0.07294741 -0.085
2026-12-31 2 48.55M 57.59M 54.5M 1 -0.02577132 -0.02059692 -0.024
2026-09-30 3 48.8M 50.7M 49.75M 2 -0.06133333 -0.03066667 -0.046